Although there have been no reports on the regulatory effects of glycosylation on collagen-related proteins during kaempferol-mediated inhibition of CRC, our findings significantly expand the understanding of Hsp47 and underscore the clinical potential of targeting Hsp47 O-GlcNAcylation as a therapeutic strategy for CRC. This evidence concerns the gene SERPINH1 and colorectal carcinoma.